Roselabs Finance (ROSELABS) Q2 FY27 Reports Zero Revenue Again as Merger Awaits NCLT Nod
The real estate subsidiary posted another quarter of zero revenue and a ₹0.06 crore loss, with its future hinging on a pending merger into parent Lodha Developers.
Roselabs Finance reported zero revenue and a net loss of ₹0.06 crore for Q2 FY27. The company's operations remain dormant, with its fate tied to a merger scheme awaiting approval from the National Company Law Tribunal.
For Roselabs Finance, a listed subsidiary of Macrotech Developers (Lodha), the quarterly earnings report is less about operations and more about a corporate clock. The company has been in a holding pattern, awaiting a merger that will fold it into its much larger parent. The September quarter results confirm the wait continues, with no revenue and a steady, small loss.
The numbers tell a story of suspended animation. Revenue was zero for the quarter, identical to the June quarter and the same period last year. The net loss held steady at ₹0.06 crore, showing no change year-on-year or sequentially.
Revenue (₹ Cr)
Profit (₹ Cr)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Period | Sep 2026 | Jun 2026 | Sep 2025 |
| Revenue (₹ Cr) | 0.00 | 0.00 | 0.00 |
| Profit (₹ Cr) | -0.06YoY 0% | -0.06 | -0.06 |
The single revenue spike in Q3 FY26, according to Flash Finance, was from the sale of building materials. Since then, the company has reported no ongoing construction or development activity.
The costs that keep ticking
With no operational income, the consistent quarterly loss is driven by recurring administrative expenses. Reports from Flash Finance and ScanX.Trade note these are primarily employee benefit costs and other operational overheads, which amounted to ₹5.47 lakh in the previous quarter.
This burn rate is small but persistent, contributing to a negative net worth. The company's 'Other Equity' stood at a negative ₹15.03 crore as of March 2026, as reported by Flash Finance.
Live Chart
· ROSELABS
(BSE)
ISIN: INE475C01012
The merger is the only plot
The company's entire strategic narrative is now the proposed merger by absorption into Lodha Developers. The scheme was filed with the National Company Law Tribunal (NCLT) Mumbai Bench on June 11, 2026, and received BSE approval in December 2025.
According to a report by Mool.ai, the swap ratio is set at 7 Roselabs shares for 1,000 Lodha shares. Court-convened meetings of shareholders and creditors were held in early October 2026 to vote on the scheme. The outcome now rests on NCLT sanction.
Key Points
- Roselabs Finance reported zero revenue for the fifth time in the last six quarters, with a steady net loss of ₹0.06 crore in Q2 FY27.
- The losses are driven by recurring administrative and employee expenses, as the company has no active real estate development operations.
- The company's future is entirely dependent on a pending merger with parent Lodha Developers, which is awaiting final approval from the NCLT.
- Roselabs carries a significantly negative net worth, with 'Other Equity' reported at negative ₹15.03 crore as of March 2026.
Hexa Perspective
This quarter underscores that Roselabs Finance exists as a corporate shell awaiting absorption. The financials are irrelevant to any assessment of a standalone business; they merely reflect the cost of maintaining a listed entity.
The investment case has narrowed to a binary event: NCLT approval of the merger. Until that decision, the stock will likely trade on speculation and liquidity flows within the small-cap segment, disconnected from any fundamental earnings power. The clock is ticking, but the timer is controlled by the tribunal.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.